Mobile Menu - OpenMobile Menu - Closed

Hearing on “Priced Out of a Lifesaving Drug: Getting Answers on the Rising Cost of Insulin”

Date: 
Wednesday, April 10, 2019 - 10:30am
Location: 
2322 Rayburn House Office Building

The Oversight and Investigations Subcommittee will hold a hearing on Wednesday, April 10, at 10:30 am in 2322 of the Rayburn House Office Building.  The hearing is entitled, “Priced Out of a Lifesaving Drug: Getting Answers on the Rising Cost of Insulin.” This will be the second hearing on the rising cost of insulin.

 

Livestream

 

Key Documents

Memorandum from Chairman Pallone to the Subcommittee on Oversight and Investigations

Opening Statement of Chairman Pallone as prepared for delivery

Opening Statement of Subcommittee Chair DeGette as prepared for delivery

 

Witnesses

Mike Mason
Senior Vice President, Lilly Connected Care and Insulins Global Business Unit
Eli Lilly and Company

Testimony


Doug Langa
Executive Vice President, North America Operations, and President of Novo Nordisk Inc.
Novo Nordisk

Testimony 


Kathleen Tregoning
Executive Vice President for External Affairs
Sanofi

Testimony


Thomas Moriarty
Executive Vice President, Chief Policy and External Affairs Officer, and General Counsel
CVS Health

Testimony


Amy Bricker
Senior Vice President, Supply Chain
Express Scripts

Testimony


Sumit Dutta, MD
Senior Vice President and Chief Medical Officer
OptumRx

Testimony

 

Issues: